Jonathan Yong
Stock Analyst at UBS
(2.64)
# 2,209
Out of 5,050 analysts
97
Total ratings
60.38%
Success rate
11.52%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $4.02 | +24.38% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.51 | +19.52% | 4 | Aug 6, 2025 | |
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $17.00 | -35.29% | 8 | Jul 15, 2025 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $28.17 | -11.24% | 2 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.90 | +51.90% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $3.02 | +164.90% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $12.97 | +100.46% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $39.53 | -64.58% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $71.26 | +34.72% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $13.42 | +138.45% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $18.69 | +461.95% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $115.08 | -30.48% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $247.22 | -6.56% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.36 | +267.10% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $201.53 | -50.38% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $850.60 | -47.10% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.92 | +310.96% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $4.14 | +1,590.82% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $17.38 | -2.19% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $147.24 | +137.71% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $19.06 | +398.56% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $3.36 | +152.97% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.50 | +74.47% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $3.13 | +443.13% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.78 | +124.87% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $80.37 | +5.77% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $179.55 | -18.69% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $36.68 | +188.99% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $227.96 | -31.13% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $261.83 | +40.55% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $249.16 | +154.86% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $78.62 | +48.82% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $22.07 | +35.93% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $475.88 | -37.38% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $204.07 | -53.45% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $316.84 | +56.23% | 1 | Oct 15, 2021 |
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.02
Upside: +24.38%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.51
Upside: +19.52%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $17.00
Upside: -35.29%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $28.17
Upside: -11.24%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.90
Upside: +51.90%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $3.02
Upside: +164.90%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $12.97
Upside: +100.46%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $39.53
Upside: -64.58%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $71.26
Upside: +34.72%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $13.42
Upside: +138.45%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $18.69
Upside: +461.95%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $115.08
Upside: -30.48%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $247.22
Upside: -6.56%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.36
Upside: +267.10%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $201.53
Upside: -50.38%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $850.60
Upside: -47.10%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.92
Upside: +310.96%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $4.14
Upside: +1,590.82%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $17.38
Upside: -2.19%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $147.24
Upside: +137.71%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $19.06
Upside: +398.56%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $3.36
Upside: +152.97%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.50
Upside: +74.47%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $3.13
Upside: +443.13%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.78
Upside: +124.87%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $80.37
Upside: +5.77%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $179.55
Upside: -18.69%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $36.68
Upside: +188.99%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $227.96
Upside: -31.13%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $261.83
Upside: +40.55%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $249.16
Upside: +154.86%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $78.62
Upside: +48.82%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $22.07
Upside: +35.93%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $475.88
Upside: -37.38%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $204.07
Upside: -53.45%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $316.84
Upside: +56.23%